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Background: Insulin resistance has been linked to exercise intolerance in heart failure patients. The aim of this
study was to assess the potential role of coronary flow reserve (CFR), endothelial function and arterial stiffness in
explaining this linkage.
Methods: 39 patients with LVEF < 35% (median LV ejection fraction (LVEF) 31 (interquartile range (IQ) 26–34), 23/39
of ischemic origin) underwent echocardiography with measurement of CFR. Peak coronary flow velocity (CFV) was
measured in the LAD and coronary flow reserve was calculated as the ratio between CFV at rest and during a
2 minutes adenosine infusion. All patients performed a maximal symptom limited exercise test with measurement
of peak oxygen uptake (VO2peak), digital measurement of endothelial function and arterial stiffness (augmentation
index), dual X-ray absorptiometry scan (DEXA) for body composition and insulin sensitivity by a 2 hr
hyperinsulinemic (40 mU/min/m2) isoglycemic clamp.
Results: Fat free mass adjusted insulin sensitivity was significantly correlated to VO2peak (r = 0.43, p = 0.007). Median
CFR was 1.77 (IQ 1.26-2.42) and was correlated to insulin sensitivity (r 0.43, p = 0.008). CFR (r = 0.48, p = 0.002), and
arterial stiffness (r =−0.35, p = 0.04) were correlated to VO2peak whereas endothelial function and LVEF were not (all
p > 0.15). In multivariable linear regression adjusting for age, CFR remained independently associated with VO2peak
(standardized coefficient (SC) 1.98, p = 0.05) whereas insulin sensitivity (SC 1.75, p = 0.09) and arterial stiffness (SC
−1.17, p = 0.29) were no longer associated with VO2peak.
Conclusions: The study confirms that insulin resistance is associated with exercise intolerance in heart failure
patients and suggests that this is partly through reduced CFR. This is the first study to our knowledge that shows
an association between CFR and exercise capacity in heart failure patients and links the relationship between
insulin resistance and exercise capacity to CFR.
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The link between insulin resistance and heart failure is
complex. Several studies have shown that insulin resist-
ance is common in heart failure of both ischemic and
non-ischemic origin. The exact mechanisms are not
known but potentially include both causal and secondary
associations. Insulin resistance has been linked to* Correspondence: snoer@dadlnet.dk
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reproduction in any medium, provided the orreduced exercise tolerance in heart failure and mechan-
isms may include both central and peripheral vascular
dysfunction [1].
In the absence of significant coronary artery stenosis,
coronary flow reserve (CFR) is a measure of microvascu-
lar function. CFR has been shown to be reduced in
patients with classic risk factors of cardiovascular disease
such as hypertension [2], obesity [3] and diabetes [4,5]
and is a strong independent marker of poor prognosis in
patients with ischemic heart disease [6]. The role of cor-
onary flow reserve in heart failure is less well described.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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shown to be reduced [7,8] and in some studies it was
also a prognostic marker of future outcome [7,9]. The
relationship between insulin resistance and CFR has not
been examined in patients with chronic heart failure.
In healthy young volunteers CFR has been related to
VO2peak [10,11]. VO2peak is one of the most important
prognostic factors in CHF patients [12] and exercise
training in heart failure has been shown to improve peak
oxygen consumption, muscle strength, symptoms and
quality of life and has become part of current guideline
recommendations. Effects are thought to be primarily
through peripheral vascular and muscular mechanisms
[13]. Few studies have examined CFR in relation to
VO2peak in heart failure patients. Recently, however, in
a small randomized trial, 4 months of exercise training
of 13 patients with primary heart failure improved both
VO2peak and CFR [14]. This study added mechanistic
insight to explain the apparent benefit of exercise train-
ing in heart failure and may also be a link to explain
improved prognosis following exercise training in heart
failure patients [15]. A possible causal web linking these
factors is depicted in Figure 1.
Peak oxygen uptake, vascular function and metabolic
function are all important prognostic markers in heart
failure. The aim of this study was to assess the potential
role of coronary flow reserve, endothelial function and
arterial stiffness in explaining the link between insulin
resistance and exercise intolerance.
Methods
Patients
The study was a local substudy based on patients screened
for inclusion to the Smartex-HF trial [16] in which
patients with chronic systolic heart failure were rando-
mized to different modalities of exercise training. The
patients were recruited from the heart failure outpatientFigure 1 A proposed linkage (non-exhaustive) between insulin
resistance, coronary flow reserve, peripheral vascular function,
left ventricular ejection fraction and exercise capacity.clinic at Bispebjerg University Hospital, Copenhagen,
Denmark. Inclusion criteria were a LVEF< 35%, clinically
stable (no signs of worsening for at least 6 weeks), mini-
mum 3 months of optimal medical treatment, and if CRT
or revascularization was performed, this should be more
then 6 months prior to inclusion. All patients had been
examined with either coronary angiography or cardiac
CT as part of their heart failure examination program
and were revascularized according to guidelines. All
patients had to have a LAD without significant sten-
osis (<50%) in order to perform coronary flow mea-
surements. Angiography was not repeated prior to the
enrolment in to the study. However, the participants were
excluded from the study if there were signs of ischemia or
ventricular arrhythmias during the maximal symptom lim-
ited bicycle exercise test. The study complied with the
Declaration of Helsinki and was approved by the science
ethics committee for the Capital Region of Denmark
(HC-2008-108). All participants gave informed written
consent.
Cardiopulmonary exercise test
All patients underwent an upright bicycle (Via Sprint
150P, Ergoline, Bitz, Germany) exercise test with breath-
by-breath gas exchange measurement (Jaeger, Mastersc-
reen CPX, Cardinal Health, Würzburg, Germany). After
3 minutes of rest on the bicycle the test was initiated
using either a protocol starting at 20 watt with a 10 watt
increase pr. minute or starting at 40 watts with a 20 watt
increase pr. minute, to ensure optimal exercise time
based on an expectation of the patients exercise cap-
acity. The patients were encouraged to continue until
maximal exhaustion. A leveling off of oxygen uptake
despite increasing workload and a respiratory exchange
ratio (RER) > 1.05 were used as criteria for maximal oxy-
gen uptake. The mean of the 3 highest consecutive 10-
second measurements before exercise terminations were
used for determining VO2peak.
Echocardiography
A complete transthoracic echocardiography was performed
using Philips IE33 (Philips Medical Systems, Andover, MA,
USA) with an S5 probe with the patients in the left supine
position. Left ventricle end diastolic (EDV) and end sys-
tolic (ESV) volumes and ejection fraction (LVEF) were cal-
culated from apical 2- and 4-chamber views using the
biplane Simpson model. Left ventricular mass (LVM) was
calculated using the formula LVM=0.8*(1.04*(LVEDD+
PWTd+SWTd)3-(LVEDD)3) + 0.6 g, where LVEDD is left
ventricle end diastolic diameter, PWTd is posterior wall
thickness in diastoly and SWTd is septum wall thickness
in diastoly, and indexed (LVMi) to body surface area
(BSA) calculated by Du Bois’ formula (BSA=0.007184 x
weight kg0.425 x height cm0.725).
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CFR can be measured non-invasively using transthoracic
Doppler echocardiography with a high success rate [17]
and this technique has been validated against invasive
measurements [18] with good results. CFR was mea-
sured using a high frequency broadband transducer (S8,
Philips). All patients were instructed to abstain from caf-
feine for 12 hours before the examination and oral use
of dipyridamole was paused for 72 hours. With the pa-
tient in the left supine position the LAD was located as
distal as possible using color Doppler either in an apical
modified two chamber view or middistal using a modi-
fied short axis view. Coronary flow velocity (CFV) was
measured using pulsed wave Doppler with a sample size
of 3–4 mm, at rest and during a 2 minute infusion of ad-
enosine at 0.14 mg kg-1 min-1. The solution was diluted
so that the infusion rate was kept at 10 ml min-1. Before
and during the adenosine infusion care was taken to
maintain the position and angle of the probe, so mea-
surements were done on the same segment of the LAD
at the same angle. During the infusion the scale of flow
velocity was changed in order to obtain optimal curves
for offline measurement. CFR was calculated as the ratio
between peak diastolic CFV during adenosine infusion
and during rest using a mean of 3 consecutive cardiac
cycles (10 cycles if the patient had atrial fibrillation).
Analyses were done offline by an investigator blinded to
the other examinations. Blood pressure and ECG were
monitored before and during the adenosine infusion.
Interobserver variability of CFR was tested on all sub-
jects and the mean difference in CFR was 0.07 with lim-
its of agreement ±0.21. The coefficient of variation (CV),
calculated as the within-subject standard deviation
divided by the mean of the observations, was 5.5%.
Intraobserver variability was tested on 10 randomly
selected examinations with a mean difference of 0.03,
limits of agreement ±0.29 and CV 7.5%. Figure 2 shows
measurement of CFR
Insulin sensitivity
Insulin sensitivity was measured using an isoglycemic
hyperinsulemic glucose clamp, with an insulin infusion
rate at 40 mU/min/m2. Subjects met in the morning
after a 12-hour overnight fast and without unusual
strenuous activity for 3 days before the clamp. Blood
glucose concentrations were measured in arterialized
blood drawn from a catheter inserted in a dorsal hand
vein. Arterialisation of the blood was achieved by placing
the hand in a heating pad. Fasting blood glucose concen-
tration was determined as the average of two blood sam-
ples, taken at t =−15 min and 0 min. Insulin was
initiated by a bolus injection, and then infused continu-
ously for 120 minutes. Glucose was measured every
5 minutes using a handheld glucose-measuring device(Accu-chek Inform, Roche Diagnostics, Indianapolis,
USA). Insulin sensitivity was defined as the steady-state
average glucose infusion rate during the final 30 minutes
of the clamp (M-value). Metabolic clearance rate of glu-
cose was calculated as the M-value divided by the pre-
vailing blood-glucose concentration in order to facilitate
comparisons between individuals at the steady-state
condition.
Body composition
A whole body dual x-ray absorptiometry scan (DEXA)
(Lunar DPX-IQ, GE Lunar Corp, Madison, WI) was per-
formed for estimation of body composition (fat mass
and fat free mass).
Vascular function
Flow mediated vasodilation measurement was performed
using Endo-PAT 2000 (Itamar, Israel) which measures
arterial pulsatile volume changes in the fingertip before
and after upper arm occlusion. The examination was
performed in the morning in a fasting state. After 5 min-
utes of baseline measurements upper arm occlusion on
one arm was sustained for 5 minutes using a blood pres-
sure cuff inflated to a minimum of 200 mmHg, while
the other arm served as a control. After the release of
the cuff the hyperemic response was recorded and the
reactive hyperemia index (RHI) was calculated as a
measure of endothelial function using the automatic
software taking the relative difference between basic and
hyperemic blood flow on the occluded arm and dividing
it with the response on the control arm, to correct for
any autonomic changes in vascular diameter.
Augmentation index is derived from pulse wave ana-
lyses and is a measure of arterial stiffness. A higher aug-
mentation index indicates more arterial stiffness [19].
Data was collected using the Endo-PAT 2000, where
pulse waveforms from the digital probes obtained before
upper arm occlusion were used to calculate the heart
rate so the results are normalized for heart rate at
75 bpm and were calculated using the Endo-PAT 2000
software.
Statistics
Unless stated otherwise values are expressed as median
and inter quartile range for continuous variables and as
number (percent) for categorical variables. Continuous
variables were compared using Students unpaired t-test
and differences in categorical variables were assessed
using chi-square test. Linear regression was used to test
the relationship between variables and correlations were
calculated using Pearsons correlation coefficient. A mul-
tivariable linear regression using standardized coeffi-
cients (SC) was done to identify independent predictors
of VO2peak. A P value of less than 0.05 was considered
Figure 2 Coronary flow reserve measurement. To the left a color Doppler image of the mid-distal part of the LAD. The top image shows the
PW recording of the blood flow velocity in the LAD during rest and the bottom shows blood flow during adenosine infusion. The scale has been
changed from rest to hyperemia. The marking represents peak diastolic flow velocity. Here the CFR is 2.45.
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STATA 11.1 (StataCorp. 2009. Stata Statistical Software:
Release 11. College Station, Texas, USA).
Results
Patient characteristics are displayed in Table 1. A total of
39 patients (33 men), without significant stenosis of LAD
were included and had a successful measurement of CFR.
Median LVEF was 31 (IQ range 26–34) and 23/39 were
of ischemic origin.
Exercise capacity
Median VO2peak was 16.2 (14.6-19.4) using total body
mass and 23.5 (20.1-27.4), when using fat free mass in the
calculation. No ventricular arrhythmias or signs of ische-
mia were seen during the test. Median test duration was
7.2 minutes (6.0-8.7) and maximum watt achieved was 90
watts (70–120). Median RER was 1.14 (1.07-1.19).
VO2peak (FFM adjusted) was higher in the patients with
non-ischemic vs. ischemic heart failure (median 26.2 vs.
22.5, p = 0.05). There were no differences between patients
with or without diabetes and atrial fibrillation.
Insulin sensitivity
Median M-value was 4.8 mg/min/kg (3.6-5.6) and glu-
cose clearance was 4.2 ml/min/kg (3.3-5.1) when using
total body mass and 6.8 mg/min/kg FFM (4.9-8.1) and
6.0 ml/min/kg FFM (4.7-7.2) respectively when using fat
free mass. When comparing patients with insulin sensi-
tivity above and below the median value 6.8 (Table 2)
the patients with higher insulin sensitivity had signifi-
cantly higher CFR and tended to have higher VO2peak
(p = 0.09), but otherwise there were no differences.Coronary flow reserve
Median CFR was 1.77 (1.26-2.42), and there were no sig-
nificant differences in CFR between patients of ischemic
and non-ischemic origin (1.57 vs. 1.99, p = 0.48), patients
with or without type 2 diabetes (1.59 vs. 1.88, p = 0.31),
with or without mitral regurgitation (1.67 vs. 1.88,
p = 0.24) or between NYHA group II and III (1.78 vs.
1.42, p = 0.48). There were also no differences in patients
with or without previous myocardial infarction, percu-
taneous coronary intervention (PCI) and coronary artery
bypass graft (CABG) operation regardless of whether the
LAD was involved or not (all p > 0.05). When comparing
high and low CFR divided by the median (Table 2),
patients with higher CFR had higher VO2peak and insu-
lin sensitivity, but did not differ with regards to periph-
eral vascular factors. The patients with higher CFR
tended to have lower EDV, ESV and LVMi, but this was
not statistically significant.
Table 3 shows correlations between the different mea-
surements. VO2peak was correlated to insulin sensitivity
(r = 0.43, p= 0.007), CFR (r =0.48, p= 0.002), augmentation
index (r =−0.35, p= 0.04) and age (r =−0.38, p= 0.02) (Fig-
ure 3). There was a correlation between CFR and insulin
sensitivity (r =0.43, p= 0.008) and augmentation index
(−0.45, p=0.007). The relationship between insulin sensi-
tivity, CFR and VO2peak was still present when removing
the 8 patients with type 2 diabetes (r = 0.48, p= 0.006 and
r=0.49, p=0.006 respectively). There were no significant
correlations between resting (r =−0.29, p= 0.07) and
hyperemic (r = 0.29, p= 0.07) CFV and VO2peak. Insulin
sensitivity was correlated to resting (r =−0.33, p= 0.04) but
not to hyperemic (r = 0.20, p= 0.22) CFV. There was no sig-
nificant correlation between CFR and EDV, ESV and LVMi.
Table 1 Baseline patient characteristics. Values are
median (IQ range) or number (%) as indicated
Patient characteristics Median (IQ range)
Age 65 (58–76)
Male sex 33 (84.6%)
BMI 26.7 (23.8-29.6)
Fat % 28.9 (20.7-33.7)
ICD 13 (33%)
Diabetes 8 (20.5%)
Atrial fibrillation 7 (18%)
Mitral regurgitation 22 (56%)
Ischemic ethiology 23 (59%)
Previous MI 19 (49%)
- involving the LAD 17 (44%)
Previous PCI 15 (38%)
- involving the LAD 13 (33%)
Previous CABG
- all involving the LAD 11 (28%)









BMI: Body mass index, ICD: Implantable cardioverter-defibrillator, MI:
myocardial infarction, LAD: left anterior descending artery, PCI: percutaneous
coronary intervention, CABG: coronary artery bypass graft, LVEF: left ventricular
ejection fraction, NYHA: New York Heart Association, ACE: Angiotensin
converting enzyme, ARB: Angiotensin-2-recepter blockers.
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sured by Endo-Pat 2000 was not correlated with CFR
(r =−0.10, p = 0.56), insulin sensitivity (r = 0.13, p = 0.45)
or VO2peak (−0.24, p = 0.16). Left ventricular ejection
fraction was not correlated to CFR (r = 0.18, p = 0.26),
VO2peak (r = 0.23, p = 0.15) or insulin sensitivity
(r = 0.14, p = 0.41).
In multivariable linear regression adjusting for age
(Table 4), CFR remained independently associated with
VO2peak (SC 1.98, p = 0.05) whereas insulin sensitivity
(SC 1.75, p = 0.09) and arterial stiffness (SC −1.17,
p = 0.29) were no longer associated with VO2peak. The
same results were achieved when using glucose clear-
ance instead of insulin sensitivity.
Discussion
The present study confirms that exercise intolerance is
related to insulin resistance in heart failure patients. The
study further shows that coronary flow reserve, a measureof coronary microvessel function, is correlated to both
exercise capacity and insulin resistance and supports a
mediating role of CFR in explaining the link between insu-
lin resistance and exercise intolerance. Peripheral endothe-
lial function and arterial stiffness were not associated with
exercise capacity and, notably, left ventricular function
was not related to either insulin resistance, exercise cap-
acity, coronary- or peripheral vascular function.
Previous studies has shown a reduced CFR in patients
with type 2 diabetes compared to patients without dia-
betes and an association between CFR and the severity
of diabetes measured as HbA1c [3] and fasting glucose
[5]. Only two studies have examined the relationship be-
tween the degree of insulin resistance and CFR in
patients without diabetes, with one study showing an in-
verse relationship between CFR and HOMA index in 45
women with suspected coronary artery disease and
angiographically normal coronary arteries [20] and an-
other showing correlation between CFR and insulin sen-
sitivity measured using a hyperinsulinaemic euglycemic
clamp in obese patients [21]. Patients with chronic heart
failure are known to have a high degree of insulin resist-
ance and many develop diabetes. The mechanisms of
this are unclear, but a common denominator in type 2
diabetes and heart failure is physical inactivity. In the
present study patients with type 2 diabetes did not have
significantly reduced CFR, although with a larger study
population there might have been a difference, but insu-
lin sensitivity was strongly correlated with CFR, indicat-
ing pre-diabetes microvascular damage.
Exercise intolerance is the most prevailing symptom in
chronic systolic heart failure and VO2peak is an import-
ant prognostic factor in this patient group. However, the
link between the degree of cardiac dysfunction and exer-
cise capacity is poorly understood, and previous studies
have shown a poor correlation between VO2peak and
LVEF [22]. In concordance, we found no correlation be-
tween these two parameters. We found a positive correl-
ation between CFR and VO2peak, which has been
shown previously in healthy young men but not in
patients with heart failure [10,11]. It is possible that
impaired microvascular function contributes to explain
the link between cardiac dysfunction and the impair-
ment inVO2peak.
Insulin resistance is highly prevalent in heart failure
[23]. In accordance with previous studies we found a
positive correlation between insulin sensitivity and
VO2peak in heart failure patients [1,24], which remained
unaffected when leaving out patients with diabetes. The
underlying mechanism for the relationship between in-
sulin sensitivity and VO2peak is not completely under-
stood. We showed that when adjusting for the effect of
CFR on VO2peak, the relationship to insulin sensitivity
was weakened and no longer statistically significant. A
Table 2 Measurements for patients divided into groups with low and high CFR and insulin sensitivity by the median
Coronary flow reserve Insulin sensitivity
Low High Low High
CFR< 1.77 CFR> 1.77 Insulin sensitivity Insulin sensitivity
n =19 n= 20 n= 19 n= 20
Exercise capacity
VO2peak (ml/min/kg FFM) 22.1 (19.1-25.5) 26.3 (21.1-29.7)
* 22.1 (19.9-26.4) 25.5 (20.3-29.5)
RER 1.14 (1.07-1.19) 1.11 (1.03-1.19) 1.12 (1.07-1.19) 1.13 (1.06-1.16)
Vascular function
RHI 1.51 (1.34-1.91) 1.59 (1.37-1.92) 1.54 (1.40-1.67) 1.62 (1.33-2.36)
Augmentation Index 12.4 (−1.6-32.8) 11.0 (−5.7-16.6) 12.8 (−3.4-27.6) 8.1 (−6.3-21.2)
Glucose metabolism
Insulin sensitivity (mg/min/kg FFM) 5.8 (4.4-6.9) 7.2 (6.4-9.2)* 4.9 (3.5-6.3) 8.1 (7.1-9.2)}
Glucose clearence (ml/min/kg FFM) 5.1 (4.4-5.9) 6.6 (5.6-8.9) 4.7 (2.8-5.8) 7.2 (6.3-9.3)}
Microvascular function
CFV rest (cm/s) 29.7 (23.0-33.0) 22.7 (18.5-27.3)} 30.0 (22.0-33.0) 23.0 (19.0-25.3)*
CFV stress (cm/s) 35.0 (29.0-43.0) 63.3 (43.0-72.2)} 41.3 (32.3-63.6) 47.3 (37.0-65.7)
CFR 1.26 (1.04-1.55) 2.39 (2.09-3.09)} 1.41 (1.04-2.14) 2.10 (1.70-3.09)}
Echocardiography
LVEF (%) 29.5 (23–34) 31.5 (27–33) 31 (26–33) 31 (26–34)
EDV (ml) 183 (144–245) 153 (112–219) 183 (113–255) 172 (138–219)
ESV (ml) 132 (95–176) 104 (75–159) 127 (77–176) 122 (90–155)
LVMi (g/m2) 131 (110–148) 104 (82–159) 128 (92–148) 126 (89–152)
CFR: coronary flow reserve, VO2peak: peak oxygen uptake, RER: Respiratory exchange ratio, RHI: Reactive hyperaemia index, FFM: Fat free mass, LVEF: left
ventricular ejection fraction, EDV: left ventricle end diastolic volume, ESV: left ventricle end systolic volume, LVMi: left ventricle mass index * p < 0.05, } p < 0.01
Values are expressed as median (IQ range).
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influences the cardiac microcirculation resulting in a
reduced CFR, which leads to an impaired exercise cap-
acity (Figure 1).
Our study did not show any relationship between CFR
and peripheral endothelial function measured using flow
mediated vasodilation. While a relationship has been
shown between CFR and flow mediated vasodilation
using brachial ultrasound in other patient populations
[25], this is not well examined in heart failure patients.
In one study of patients with dilated cardiomyopathy no
correlation between CFR using echocardiography and
flow mediated vasodilation was found [26]. Similarly, a
study comparing patients with non-ischemic heartTable 3 Correlations and p-values between different measure
Age Augmentation index
VO2peak −0.37 (0.02) −0.35 (0.04) −0.2
CFR −0.18 (0.27) −0.45 (0.007) −0.1
LVEF 0.05 (0.76) 0.12 (0.48) 0.0
Insulin sensitivity −0.14 (0.41) 0.12 (0.50) 0.1
RHI −0.03 (0.85) 0.44 (0.008)
Augmentation index 0.14 (0.44)
RHI: Reactive hyperemia index, LVEF: Left ventricular ejection fraction, CFR: Coronarfailure to healthy controls found that flow mediated
vasodilation and CFR measured using positron emission
tomography were correlated in the healthy controls but
not in the patients with heart failure [27]. Interestingly,
in a small study of dogs with pacing induced heart fail-
ure, CFR was reduced with progression of heart failure,
but coronary endothelial function was preserved until a
late stage of heart failure [28]. Thus our results are con-
sistent with the literature in finding no association
between CFR and endothelial function.
The present study shows a negative correlation between
CFR and augmentation index, which is as measure of stiff-
ness in the large arteries. Only one previous study has
related CFR to augmentation index [29]. In this study ofments
RHI Insulin sensitivity LVEF CFR
4 (0.16) 0.43 (0.007) 0.23 (0.15) 0.48 (0.002)
0 (0.56) 0.43 (0.008) 0.18 (0.26)
8 (0.65) 0.14 (0.41)
3 (0.45)
y flow reserve.
Figure 3 Scatter plots with linear regression lines between VO2peak and CFR (upper left), VO2peak and insulin sensitivity (upper right),
insulin sensitivity and CFR (lower left) and augmentation index and FR (lower right).
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disease, the patients with higher augmentation index and
pulse wave velocity had a lower CFR. In a normal elastic
aorta the pulse wave reflects from the periphery and
returns to the heart in diastole, which improves the dia-
stolic filling of the coronary arteries. With aorta stiffening
the pulse wave returns during systole resulting in
increased afterload and myocardial oxygen demand which
could mean, that a reduced CFR in heart failure patients
without significant coronary artery stenosis might not onlyTable 4 Univariate and multivariable linear regression
with VO2peak as the dependent factor
Univariate beta p Multiple beta p
Age −0.23 0.02 −0.18 0.04
Insulin sensitivity (SC) 2.86 0.007 1.75 0.09
CFR (SC) 3.07 0.002 1.98 0.05
RHI (SC) −2.01 0.16 Ns
Augmentation index (SC) −2.21 0.04 Ns
LVEF 0.25 0.15 Ns
SC: Standardized coefficient, CFR Coronary flow reserve, RHI: Reactive
hyperemia index, LVEF: Left ventricular ejection fraction.be due to impaired coronary microcirculation, but that a
reduced diastolic filling can be a participating factor. Insu-
lin sensitivity and augmentation index were independently
associated with CFR, suggesting that they influence CFR
through different mechanisms. However, this finding
remains to be confirmed in other studies.
Previous studies have shown that about 50% of asymp-
tomatic patients with type 2 diabetes have signs of dia-
stolic dysfunction [30] and that diastolic dysfunction is
associated with insulin resistance in patients with sus-
pected coronary artery disease without diabetes [31]
without systolic heart failure. In patients with systolic
heart failure, patients with type 2 diabetes have signifi-
cantly higher E/e’ than patients without diabetes [32].
Although we did not include measures of diastolic func-
tion the present study, a possible mechanism between
insulin sensitivity and diastolic dysfunction might be
impaired coronary microvascular function.
A reduced CFR has been shown to be an independent
predictor of poor outcome in patients with dilated cardio-
myopathy [8] and in a mixed population of heart failure
patients [33]. In the present study we find a relationship
between CFR, VO2peak and insulin sensitivity, which also
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suggesting that these risk factors are closely linked. Im-
proving VO2peak and insulin sensitivity through exercise
training could also improve CFR as has been shown in a
recent study of heart failure patients [14]. CFR has also
been improved through other interventions such as
weight loss in obese women [34] and after treatment with
a beta-1 receptor blocker in dilated cardiomyopathy [35].
However, it has not yet been shown whether improve-
ment in CFR through e.g. exercise training is followed by
an improvement in prognosis for heart failure patients.
An ongoing study will determine if CFR can improve after
different modalities of exercise training in heart failure
patients, and if any changes will correspond to changes in
peak oxygen uptake, metabolic fitness and in augmenta-
tion index.
Limitations: Although the study is limited in size this
is somewhat counteracted by the precision of the mea-
sures used: insulin sensitivity and glucose clearance were
assessed by hyperinsulinemic isoglycemic clamp, the
gold standard, and adjusted to fat free mass from DEXA
scan. VO2peak was a true maximum test as indicated by
the high RER values. The cross-sectional nature of the
study impedes causal inference and any conclusions
regarding potential effects of intervention must therefore
remain speculative. The patients had all had a LAD
without significant stenosis at a previous coronary angi-
ography or coronary CT-scan, but the examination was
not repeated at the time of the study, meaning that some
of the patients potentially could have developed a signifi-
cant LAD-stenosis. All of the patients did however per-
form a maximal symptom limited cardiopulmonary
exercise test at enrolment in to the study without chest
pain or signs of ischemia on the ECG minimizing the
chances of a significant LAD-stenosis.Conclusion
Our study confirms that insulin resistance is associated
with reduced exercise tolerance in heart failure patients
and suggests that this is partly due to reduced coronary
flow reserve. This is the first study to our knowledge
that shows an association between CFR and exercise
capacity in heart failure patients and links the relation-
ship between insulin resistance and exercise capacity to
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